From “Trump” to “Russian” to “dentist,” the only way to gaze into the Epstein-files abyss is through a keyword-size hole.
An analysis finds that pharmas frequently file multiple similar patents on drugs, then use them as the basis for questionable litigation against would-be competitors.
Pam Bondi wrote in a Saturday letter the DOJ has released "all" Epstein-related files and listed a number of "politically ...
This list will be updated and includes people who have faced concrete consequences, such as the loss of their position, as a ...
Patrick Healy, an assistant managing editor who oversees The Times’s journalistic standards, talked with four of the journalists who are working on the Epstein files to kick around those questions.